Cassava Sciences, Inc. Profile Avatar - Palmy Investing

Cassava Sciences, Inc.

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational dia…

Biotechnology
US, Austin [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of SAVA's Analysis
CIK: 1069530 CUSIP: 14817C107 ISIN: US14817C1071 LEI: - UEI: -
Secondary Listings
SAVA has no secondary listings inside our databases.